Advicenne S.A. (EPA:ALDVI)
France · Delayed Price · Currency is EUR 1.200
-0.114 (-8.68%)
Jun 3, 2026, 5:35 PM CET
Advicenne Revenue
In the year 2025, Advicenne had annual revenue of 6.40M EUR with 21.56% growth. Advicenne had revenue of 3.14M in the half year ending December 31, 2025, a decrease of -12.66%.
Revenue
6.40M
Revenue Growth
+21.56%
P/S Ratio
2.99
Revenue / Employee
582.18K
Employees
11
Market Cap
19.12M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.40M | 1.14M | 21.56% |
| Dec 31, 2024 | 5.27M | -97.00K | -1.81% |
| Dec 31, 2023 | 5.37M | 1.65M | 44.41% |
| Dec 31, 2022 | 3.72M | -9.00K | -0.24% |
| Dec 31, 2021 | 3.72M | 233.00K | 6.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| genOway Société anonyme | 20.96M |
| Nicox | 16.77M |
| Poxel | 7.66M |
| Aelis Farma | 2.08M |
| Plant Advanced Technologies | 1.97M |
| Oncodesign Precision Medicine Société anonyme | 1.81M |
| Aton | 656.93K |
| GenSight Biologics | 652.00K |